Schedule 13D/G History

Brii Biosciences Ltd

Holdings History for AN2 Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 927K shares
Security Ownership: 3.1%

Brii Biosciences Limited ownership in AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX)

2025-02-14 - Brii Biosciences Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 927K shares of AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX). This represents 3.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Brii Biosciences Limited	3.1%		$1.26M	927K			$1.36	13G/A	12/31/2024	14 Feb 2025 16:30:17